Rheumatoid Arthritis | plaquenil reduces cardiovascular risk

Rheumatoid Arthritis | plaquenil reduces cardiovascular risk


A simple RA drug that can cut down the risk
of heart attacks and strokes… next First-Line RA Drug Linked to Decreased CVD
Risk Kate Johnson writing for Medpage Today reported
the antimalaria drug hydroxychloroquine (Plaquenil) that is used as first-line therapy in patients
with rheumatoid arthritis (RA) is also associated with reduced cardiovascular risk, especially
at higher doses, a new study shows. “This is the first study to answer this question
specifically,” said Michael Shapiro, MD, from the Sackler Faculty of Medicine at Tel Aviv
University in Israel, who suggested a “protective effect” of the drug.
The retrospective analysis included 514 RA patients ages 18 years or older who were treated
at a single institution between 2003 and 2013. Comment: I use Plaquenil sparingly for patients
with mild RA. Nonetheless this study shows that even a mild drug can have beneficial
effects.

4 Comments

  • Paddy Voakes says:

    I was prescribed Plaquenil recently to treat my Psoriatic Arthritis as Methotrexate did not agree with me. Plaquenil has worked so well for me. No more pain and no more nasty MTX side effects.
    Love the videos Nathan.

  • dean Strathras says:

    I will be starting plaquenil later in june…i have ti have an eye exam completed before i can start it. I am very hopeful this drug will agree with me and will protect my poor heart/organs and joints, and if it could help with the constant achey pain-well maybe im being too hopeful…but im trying to stay positive. I am only 32 and have always worked more physical labor jobs to support myself-needless to say-it has been getting more and more difficult.

  • MyMonkeyMinions says:

    This drug has made a difference. Combined with getting off Celebrex (recommended by Rheumatologist).

  • tomco78 says:

    Liar read FDA report causes branch blockage, heart attacks, angio edema!

Leave a Reply

Your email address will not be published. Required fields are marked *